Background Normal urine catecholamine values in patients with phaeochromocytoma is an occasional finding and may lead to a missed diagnosis. Additional urinary free metadrenaline analysis may be of value in this situation.
Introduction
Phaeochromocytoma, is a rare, life-threatening tumour. Its diagnosis is important to make since, if detected early, surgical treatment is usually successful.!" 3 Although measurement of 24-h urinary free catecholamine excretion has been described as a preferred means of phaeochromocytoma detection," there have been a number of reports of proven cases where these results were not abnormal. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Some studies have indicated that urinary metadrenalines may be a better test than the free catecholamines for detecting the presence of phaeochromocytoma.v't-P The metadrenalines were first identified as metabolites of the catecholamines in humans in 1960. Urinary excretion is largely in the form of sulphate conjugates. 13 In the absence of neural crest tumours, up to a half of the urinary metadrenaline (MA) may be found in the free (unconjugated) form, whereas less than 200,'h ofnormetadrenaline (NMA) is • unconiugated.lv" © 2002 The Association of Clinical Biochemists A much higher proportion of the native catecholamines are present in urine as the unconjugated form than are the metadrenalines, and this fraction is similar in normal, hypertensive and phaeochromocytoma patlents.!" However, in patients with phaeochromocytoma, not only is the urinary output of the metadrenaline metabolites found to be increased. there is a disproportionate increase in the unconjugated fraction. particularly for NMA.1H!! More recently. in a series of revealing articles, Eisenhofer et at. have shown that measurement of unconiugated metadrenalines in plasma provides a highly sensitive test for the detection of phaeochromocytoma. [20] [21] [22] Hence, measurement of urine free metadrenalines may improve tumour detection. particularly in situations where the excretion of the catecholamines themselves is normal. The ASTED™ system (Gilson Medical, Middleton WI, USA) for measuring catecholamines is also capable of measuring urinary free metadrenaltnes.O-o The purpose of this retrospective study was to examine cases of histologically confirmed phaeochromocytoma with normal catecholamine excretion and to assess the possible value of inclusion of measurement of the free metadrenalines in the test profile.
Patients and methods
From June 1997 to July 2001. 24-h urine collections were obtained from approximately 3340 patients undergoing investigation for phaeochromocytoma. Urine was collected into opaque polyethylene bottles containing 10 mL concentrated hydrochloric acid. On receipt in the laboratory. specimens were checked for adequate acidity (pH < 4) using pH paper (BDH Laboratory Supplies. Poole. England). urine volume recorded. and a 20 mL aliquot obtained. The accuracy of collection was assessed by measuring creatinine output.
Noradrenaline (NA). adrenaline (AD). dopamine (DA). NMA. MA and dihydroxybenzylamine as internal standard were obtained from Sigma-Aldrich Co. Ltd. Poole. England. All other chemicals were obtained from BDH Laboratory Supplies. Poole. England.
The high-performance liquid chromatography (HPLC)methods and protocols employed for the investigation of the presence of phaeochromocytoma evolved gradually over the period of study. Prior to 1996, the catecholamines NA. AD. DA plus their carboxylic acid metabolites. vanillylmandelic acid (VMA) and homovanillic acid (HVA). were measured using in-house methods described previously.2<;-27 Prom 1996 onwards. VMA and HVA were measured using an automated HPLC kit method (BioRad Laboratories. Hemel Hempstead. UK. cat. no. 195-5974) on Gilson equipment. which included the ASPECTM automated sample preparation and injection unit (Gilson Medical Electronics Inc.. Middleton WI, USA). and an ESA Coulochem II coulometric detector. which consisted of a Model 5021 conditioning cell set at zero volts followed by a dual channel Model SOlO analytical cell. set in series. at +0·18 volts and +(HO volts. respectively (ESA Inc.. Chelmsford MA. USA). Urinary free catecholamines and free metadrenalines were analysed simultaneously also by automated HPLC using the Gilson ASTEO™ system. The method and conditlons were as described by Green et al. 21 [l.e. HPLC column ISOmm x 4·6 mm l.d, packed with 5 11m particles of Spherisorb OOS2 (Phase Separations. Queensferry. IJK); mobile phase: 125 mmol/L diammonium hydrogen orthophosphate; n·5 mrnol/L heptane sulphonic acid; 0·25 mmol/L EOTA; and 20 ml/L methanol, pH 3,5: delivered at a now rate of 2 mL/min]. The detection system was also an ESA Coulochem II coulometric detector and used the protocol described by weinkove'" (l.e. Model 5021 conditioning cell set at Inter-assay coefficients of variation (CVs) were determined by replicate analysis of a commercial quality control material. Lyphochek II (BioRad Laboratories Ltd, Hemel Hempstead. UK, cat. no. C-395-1O). Accuracy and linearity of free NMA (fNMA) and free MA (fMA) measurements were assessed by comparing results obtained with consensus mean values for Randox International Quality Assessment Scheme (RIQAS) external quality control samples (Randox Laboratories Ltd. Crumlln, UK). and with the quoted spiking values of recovery specimens issued by UK National External Quality Assesment Scheme (UKNEQAS. Wolfson EQA Laboratory. Birmingham. UK). Specimens from the RIQAS external quality assessment scheme are one in 20 dilutions of normal human urine spiked to varying degrees with unconjugated NMAand MAand hence the endogenous values for these analytes are rendered numerically insignificant when compared with the final concentration. The recovery specimens from UKNEQAS are undiluted urine also spiked with unconjugated metadrenalines generally at higher concentrations than RIQAS specimens. and in this case the comparison figure is the spiking amount added. Comparison between HPLC values and those of UKNEQAS and RIQAS specimens were carried out according to the regression procedure of Passing and Bablok.P'
Reference ranges for the catecholamines and for VMA and HVA were based on published data from 50 hypertensive patients being investigated for phaeochromocytoma but not subsequently found to have the disease. 25.27 Neither dietary nor drug restrictions were imposed. Since the values for NAand AD showed a positive skew. the results were normalized by logarithmic transformation and the upper reference limits were calculated as mean plus two standard deviations of the log-transformed data." For fNMA and fMA. provisional upper reference limits were determined by analysis of 24-h urine specimens from 230 adult patients (l30 women. 100 men. median age 50 years. range 18-86 years) who were being investigated for possible phaeochromocytorna. but not subsequently found to have the disease. Since both fNMA and fMA also showed a positive skew. upper reference limits were determined non-parametrically and represent the 97·5 percentiles.
Histology reports on patients with phaeochromocytoma were scrutinized to determine tumour size and location; however, some histopathologists recorded only tumour weight. Others recorded tumour volume as a sphere with a diameter and in this situation volume was calculated as ltd l/6 where d is the quoted diameter. Most recorded tumour volume in three dimensions as a cuboid of described length. breadth and height. In some instances neither weight nor volume of post-operative tumour tissue was documented. This was also the case when histological diagnosis was made by biopsy without subsequent surgery.
Chromatographic separation and detection
The chromatographic separation of catecholamines and metadrenalines on the ASTEDTM system for a 2000 nmol/L aqueous standard solution is shown in Fig. 1 . As can be seen, there is a less sensitive response for isomolar concentrations of the metadrenalines compared with the native catecholamines. Free normetadrenaline yields only 30% and fMA only 20% of the peak area signal produced by NA. 
Results

Reference ranges
The provisional upper limits for the non-phaeochromocytoma reference group were determined to be 650 nmol/24 h for urinary fNMA. and 350 nmol/24 h for urinary fMA. giving a maximum combined upper reference limit oflOOO nmol/24 h.
Patients
The results for six patients with normal catecholamine excretion yet subsequently found to have histologically confirmed phaeochromocytoma are detailed in Table 1 .
Case 1
An 82-year-old gentleman presented with weight loss, anorexia and malaise. Abdominal ultrasound examination revealed a mass in the right adrenal which was confirmed by biopsy to have the histological appearance of a phaeochromocytoma with positive immunohistochemical staining for chromogranin and neurone-specific enolase. He died within 10 days of his admission.
Case 2
This 63-year-old gentleman was admitted with a 4-day history of chronic chest pain. palpitations. and was found to have elevated blood pressure (174/ 78 mmHg). Whilst in hospital, he exhibited classical episodes of headache. sweating, tachycardia and a systolic blood pressure of 250 mmHg. Each episode lasted approximately 10 min. An abdominal computerized tomography (CT) scan showed a mass in the right adrenal, confirmed by a positive meta-idobenzyl guanidine (MIBG) scan. He was treated by surgical removal of his right adrenal. Phaeochromocytoma was confirmed by histological appearance and positive immunohistochemical staining. which was confirmed by subsequent biopsy. to have the histological appearance of a phaeochromocytoma. Despite none of the usual symptoms of phaeochromocytoma, an MIBG scan showed increased uptake of isotope in the right adrenal. He was treated by surgical removal of the right adrenal. and phaeochrornocytoma was verified by histological appearance.
Case 4
This 35-year-old gentleman presented with a rightsided neck lump which he had been aware offor about 5 years. He reported no episodes of palpitations. flushing or other symptoms suggestive of phaeochromocytoma, and was normotensive. Imaging studies showed bilateral carotid body tumours. These were removed in two separate operations and both were confirmed as showing typical histological features of extra-adrenal paragangliomas.
Case 3
A 44-year-old gentleman was admitted with acute abdominal pain. An elevated serum amylase confirmed a diagnosis of acute pancreatitis. However. abdominal CT identified a right-sided adrenal mass.
Case 5
A 66-year-old gentleman was admitted for investigation of a recent history of weight loss. anxiety. chest pain and disordered liver function tests. Abdominal ultrasound, CT and magnetic resonance imaging scanning revealed a small lesion in the right adrenal. An MIBG scan showed increased uptake of isotope in the right adrenal. He was treated by surgical removal of his right adrenal. Phaeochromocytoma was confirmed by histological appearance and positive immunohistochemical staining.
Case 6
This 32-year-old lady presented with abdominal distension. On abdominal examination she was found to have a palpable mass arising from the pelvis that was confirmed by ultrasound. Although thought to be an ovarian carcinoma, histology of a biopsy taken at laparotomy indicated an extra-adrenal phaeochromocytoma, confirmed by immunohistochemical staining and electron microscopy. Subsequent MIBG scanning and CT scan indicated extensive metastatic tumour spread throughout the pelvic area. She died within 3 months of diagnosis.
As can be seen from Table 1 , four patients (cases 1, 2, 3 and 5) had right-sided, intra-adrenal phaeochromocytorna. whilst in the remaining two, the location was extra-adrenal. In the last patient, from 1995 (case 6), urinary VMA excretion was slightly elevated. Results of free metadrenalines were not yet available at the time of this case. Of the remaining five patients for whom catecholamine and free metadrenalines results were available, only case I, with an intra-adrenal phaeochromocytoma, showed all results within normal limits. Case 5 showed elevation of adrenaline in only two out of five urine collections. Cases 2, 3 and 5 with intra-adrenal tumours showed consistent elevations in one or both of the free metadrenalines. In one of these three (case 2),VMAwas also elevated. In case 4, with bilateral carotid body tumours, despite the histological appearance of paragangliomas. all the results remained within normal limits.
Tumour volume data were available for four of the six cases with normal catecholamines. These showed an average volume of 35·7 mL. By comparison. 30 surgically and histologically confirmed cases of phaeochromocytoma, where one or more of the urinary catecholamines were increased, showed a mean (range) tumour volume of 110-7 mL (8-0-367-4 mL).The mean (range) catecholamines for these 30 patients were: NA = 8190 (540-31571) nmol/24 h: and AD =2062 (30-18320) nmol/24 h. Urinary free metadrenalines results were available for 15 patients. They all showed an elevation in one or both of these analytes: mean fNMA = 7091 (886-21956) nmol/ 24 h and mean fMA =1182 ( < 100-5171) nmol/24 h.
Using Spearman rank correlation for these 15 plus the four patients from Table 1 with available volume measurements. (fNMA+fMA) correlated positively with tumour volume (r s =0·66. P < 0-01) (see Fig. 4 ).
Phaeochromocytoma with normal urinary catecholamines 563
The catecholamines (NA+AD) did not show a correlation with tumour volume (r s =0,45, P> 0'(5).
Discussion
Chromatographic separation and detection
Although the metadrenaline peaks are adequately separated from those of the catecholamines on the ASTED™ system (see Fig. 1 ) it was not optimized for urinary free metadrenalines analysis. Further work would be required to establish optimal conditions. Recent developments in the field of total metadrenaline analysis in urine specimens have included. in addition to HPLC with electrochemical detection (HPLC-ECD),30 the application of radioimmunoassay (RIA),31 gas chromatography-mass spectrcmetryV and liquid chromatography-tandem mass spectrometry"
Precision
Mass spectrometry methods are able to achieve interassay CVs of less than 9%.32.33 A recently described HPLC-ECD method capable of being adapted to urinary free metadrenalines assay, including the dopamine metabolite 3-methoxytyramine, exhibited inter-assay CVs in the range 9-12°j".lO With the ASTED™ system, used as described for fNMA and fMA assay, the inter-assay CVs at comparable concentrations were very similar to those reported for urinary metadrenaline analysis by RIA (NMA, 16'}{" MA. 12%).31
Accuracy
The ASTEDTM method compared reasonably well with the target values from external quality assurance specimens. A useful future development would be to supply quoted respective target values for the unconjugated moiety of each of the metadrenalines.
Interferences
Unfortunately, HPLC-ECD assays for metadrenalines are subject to interferences by substances, often of unknown composition, which co-elute with the peaks of interest, and failure rates have been variously quoted as affecting 7% 34 or In;,32 of urine specimens. A distinct disadvantage of the ASTEOTM system for free metadrenaline analysis is the high failure rate due to interferences. These interferences can be largely eliminated by employing MS or RIA technlques.U-V However, in the present study, the analytical failure amongst patients subsequently found to have phaeochromocytorna was minimal.
Reference ranges
There are several issues to be considered when attempting to establish reference ranges for urinary catecholamines and metadrenalines. One of these issues is the choice of reference population. Except in the situation of screening family members of individuals with familial forms of phaeochromocytoma, the use of a healthy population is inappropriate and would result in an unacceptably high number of false positives. It is more appropriate to use data from patients suspected of having a phaeochrornocytoma but where the diagnosis was subsequently rejected. 34. 35 Another issue to be considered is the population distribution. For example, the frequency distributions for urinary output of both NA and AD in a reference population show a positive skew 25 and an assumption of normality would also increase the number of false positives unless it is taken into account. 35 Such data may be normalized by logarithmic transformation. 25.34.35 The reference intervals for urinary catecholamines used in the present study were established taking account of both factors, and are similar or identical to those quoted by others employing HPLC-ECDtechnlques.? 34
Patients
There are a number of characteristics of phaeochromocytoma that appear to be associated with normal urinary catecholamine output.
Clinically silent phaeochromocytoma
Of the six cases described with normal catecholamines, only case 2 exhibited the usual signs and symptoms of phaeochromocytoma. In cases I, 3 and 5. an adrenal mass was discovered incidentally by imaging in the absence of symptoms or clinical findings specifically suggestive of adrenal disease, and hence may be described as 'adrenal incidentalomas'. 30 In a recent report from the Mayo Clinic, approximately 5% of patients with adrenal incidentalomas proved to have phaeochromocytoma -approximately lO'X, of adrenal phaeochromocytomas presented in this way. They also reported that 7% of patients with adrenal phaeochromocytoma had normal 24-h urinary catecholamlnes.F It has been strongly recommended that a hormonal evaluation be performed in all patients with adrenal incidentaloma, even if normotensive, to exclude the presence of a phaeochromocytoma. II! However, it is clear from the present study, that a finding of normal urine catecholamine excretion by itself cannot successfully rule out a diagnosis of phaeochromocytoma in all cases. In one report of an asymptomatic and normotensive patient with a 5 em adrenal incidentaloma, elevated concentrations of free metadrenalines in plasma provided the only biochemical evidence of phaeochromocytoma. However, urinary free metadrenalincs were not measured in that case." Ann Clin Biochem 2002; 39: 557-566
Tumour size
The average tumour volume in four patients described showing normal urinary catecholamines was only one-third that of 30 other cases of phaeochromocytorna, where one or more of the catecholamines were increased. However, urine catecholamine excretion is a poor predictor of tumour size, and output seems to be determined by tumour catecholamine concentration and turnover rate.t'' For the 19 cases of'phaeochromocytoma in the present study, for whom free metadrenaline results were available, there was no correlation between (NA+AD) and tumour volume, although a significant correlation was demonstrable between (fNMA+fMA) and tumour volume (see Fig. 4 ). Two similar studies in phaeochromocytoma patients have also shown no correlation between the urine or plasma concentrations of the parent catecholamines and tumour mass, yet both studies found significant positive relationships between either urinary metadrenallnes.v' or plasma free metadrenallnes-" and tumour mass.
It has been shown in patients with phaeochromocytoma that. regardless of tumour catecholamine secretion, more than 90% of the free metadrenalines occurring in plasma are derived from metabolism of catecholamines to metadrenalines within tumours before release into the circulation, and not from catecholamines metabolized after their secretion into the circulation. Hence, it appears that the free metadrenalines in plasma or urine provide a better indicator of tumour size than do catecholarntnes.i"
Tumour location
Phaeochromocytoma describes a paraganglioma of the adrenal medulla whose cells produce a typical brown colour on reaction with potassium dichromate reagent due to their catecholamine content (chromaffin tumourj.V However. in addition to the adrenal medulla, chromaffin-positive. catecholaminesecreting paragangliomas may be found in many other sites including the carotid body (case 4)43 and the abdomen (case 6), and are described as extra-adrenal phaeochromocytomas.t-r" (For an anatomical classification of paragangliomas see Fonseca and Bouloux, 1993. 44) Extra-adrenal phaeochromocytomas may have approximately lO-fold lower tissue concentrations of AD and MA than tumours located in the adrenal glands.i'' However, most retroperitoneal paragangliomas are non-functional and a high proportion are maltgnant.t'' as in case 6. For some malignant phaeochromocytornas, dopamine and its metabolites 3-methoxytyramine and HVA are important indicators. 4 h. 4 7 Similarly. paragangliomas of the carotid body may also be non-functional or else secrete dopamine or its metabolites 3-methoxytyramine and HVA. 4 /l
Episodic secretion
In addition to clinical silence. small size and extraadrenal location. a further feature of phaeochromocytorna that may be associated with normal urinary catecholamine results. is the episodic nature of hormone release. and false negative results may be obtained if patients are assessed at times when a catecholamine-secreting tumour is not hormonally acttve.t? For example. Tormey and Fitzgerald have amply demonstrated the importance of persistence in biochemical investigation where clinical suspicion is heightened. In one of their reported cases. only three out of nine urine specimens from the same patient showed elevated catecholamine excretion. whilst urinaryVMA remained within normal limits throughout.? This was similar to case 5 of the present study where only two out of fiveadrenaline results exceeded the upper reference limit. whilst VMA and NA remained normal. However, urinary fMAwas consistently elevated (seeTable 1).Unlike the catecholamlnes, the free metadrenalines appear to be released from these tumours in a more sustained manner.r" It is to be hoped that essential further developments in the measurement of the free metadrenallnes, including 3-methoxytyramine. in plasma and urine. will contribute significantly to the avoidance of false negatives in the diagnosis of this important tumour group.
